MetaCap

CapsoVision (CV) vs Electromed (ELMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

CapsoVision (CV) has outperformed Electromed (ELMD) over the past year, gaining 16.8% versus a loss of 11.3%. CapsoVision is the larger company by market cap ($327.6 million vs $187.8 million), about 1.7 times the size. Electromed converts more of its revenue into profit, with a net margin of 15.3% versus -186.8%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CV+16.83%ELMD-11.31%
+185%+82%-21%
Nov 21, 20251 yearNov 20, 2026
CV+38.86%ELMD+10.59%
+212%+91%-30%
Jun 30, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CV versus ELMD key metrics
MetricCVELMD
Share price$6.11$22.98
Market cap$327.56M$187.84M
1-day change-3.17%-1.20%
YTD return-42.84%-21.09%
1-year return+16.83%-11.31%
5-year return—+99.13%
P/E ratio (TTM)—16.65
Forward P/E—37.67
EPS (TTM)$-0.42$1.38
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$13.55M$73.78M
Revenue growth (YoY)+15.29%+15.28%
Net income (latest FY)$-25.32M$11.30M
Gross margin52.92%78.54%
Operating margin-188.25%18.82%
Net margin-186.77%15.32%
52-week high$15.37$47.40
52-week low$4.50$22.67
Distance from 52-week high-60.25%-51.52%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+55.48%+111.05%
Average volume173.59K83.59K
Shares outstanding53.61M8.17M
Employees99195
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CV has outperformed ELMD by 28.1 percentage points over the past year.
  • Electromed is more profitable, keeping 15.3 cents of every revenue dollar as net income versus -186.8 cents for CapsoVision.

About CapsoVision

CV stock →

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 99 employees

About Electromed

ELMD stock →

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 195 employees

CV vs ELMD FAQ

Which is bigger, CapsoVision or Electromed?

CapsoVision (CV) is larger, with a market capitalization of $327.56M compared with $187.84M for Electromed (ELMD).

Which stock has performed better over the past year, CV or ELMD?

CV returned +16.83% over the past 12 months, compared with -11.31% for ELMD (price return, excluding dividends). Past performance does not predict future results.

Are CapsoVision and Electromed in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons